Updated COVID-19 Recommendations for Patients with Psoriatic Disease

With the novel coronavirus outbreak continuing to evolve as a public health concern, the need for tailored medical guidance and updated clinical recommendations is emerging across specialties. General guidelines issued by the CDC and WHO, such as social distancing and self-isolation when possible, apply to all individuals. However, the coronavirus may have challenging implications on the …

The Psychosocial Burden of Atopic Eczema: Prevalence of Mental Illness in AE Patients

Atopic dermatitis (AD), or eczema, is a cause of suffering for many U.S. adults, impacting not only their skin health but also productivity levels, mental health, and quality of life. Current data reveals the high prevalence and disease burden of atopic eczema, with an estimate of 16.5 million adult cases and 6.6 million of those …

Latest Clinical Practice Guidelines for Psoriasis Phototherapy Treatment 

Out of the estimated 125 million individuals suffering from psoriasis worldwide, many may be capable of sufficiently managing the condition with the use of topical prescriptions alone. However, in the case of nearly 25% of patients these methods do not suffice – often, disease severity necessitates alternative options, including systemic and biologic treatments. These interventions are …